The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis – results from 14 European countries - BMC Rheumatology Objectives To quantify the influence of lifestyle factors on tumour necrosis factor inhibitor (TNFi) treatment response, in axial spondyloarthritis (axSpA). Methods Data on biologics-naïve adults with...

📰 New in BMC Rheumatology:

Lifestyle factors like smoking, obesity & alcohol impact TNFα inhibitor outcomes in axial SpA (14-country study). Supports integrated care in rheumatology.

Read article👉 shorturl.at/cmBY6

#Rheumatology #AxialSpA #TNFalpha #LifestyleMedicine #BMC #EuroSpA #Publication

TNFα: Friend or Foe? While TNFα plays a key role in immune defense, chronic inflammation is linked to neurodegeneration. New studies suggest blocking TNFα could help reduce Alzheimer’s risk. Could this be a breakthrough in prevention? 🔬🧪
#NanoNewron #Neuroscience #AlzheimersResearch #TNFalpha

TNFα and Alzheimer’s—The Science is Clear
Inflammation is a key driver of neurodegeneration, and TNFα inhibitors show promise in lowering Alzheimer’s risk. Is it time to rethink how we approach brain aging? 🧠⏳
#AlzheimersAwareness #BrainHealth #Neuroinflammation #TNFalpha

KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.

#kiss1 #suppresses #TNFalpha #breastcancer #cell #invasion #inhibition #NFkappaB #genetic #Houston #Texas

husslook.tumblr.com/post/534252637…